Developer of air and water filters, FiltersFast.com, is once again joining the Cystic Fibrosis Foundation (CFF) to support the fight to find a cure for cystic fibrosis (CF) by participating in the “Xtreme Hike for a Cure.” The event will be hosted by the foundation on April 18 and includes a hiking route of 30 miles to help raise both awareness and funds to support the disease.
The president of FiltersFast.com, Ray Scardigno, is going to represent the company’s team in the Xtreme Hike of the Charlotte, NC Chapter. Scardigno not only has a personal connection to the cause, but he has also committed to help find a cure for this chronic disease that affects 30,000 people in the United States, causing problems in the lungs and digestive system.
The company will support the CFF by raising funds at the Xtreme Hike for a Cure, as well as by providing their customers with the opportunity to donate to Team Filters Fast, as announced in a press release. The donations, which will be used to support programs focused on CF research, care and education, are totally tax-deductible.
FiltersFast.com is encouraging its clients to contribute through their donation page available here, or when checking out from their website, promising to match the donations up to $7,500. FiltersFast.com, which was created in 2004 with the purpose of simplifying the lives of their customers, is committed to helping the CFF, as well as engage their clients in doing the same.
Last year, the efforts from the company and their customers throughout the two months prior to the Xtreme Hike for a Cure collected a total of $23,408 in donations. Each client was encouraged to donate $1.00 upon checkout, while FiltersFast.com offered to match the donated amount up to $7,500. On April 26, 2014, Ray Scardigno took part in the Xtreme Hike for a Cure in the Appalachian Trail.
This is the sixth edition of the nationwide fundraising event, which is comprised of a series of regional events. The participants are invited to prepare themselves for the hike, since it is charted across rough terrain in difficult conditions. The funds raised will be used to support research, such as the projects from specialty biopharmaceutical company Shire, which is developing a technology to maintain and/or restore lung function, and protect against respiratory infections, two primary health concerns in CF patients.